Karin Jooss
- Genetics top 0.5%
- Virus-based gene therapy research 26
- Oncology top 1%
- CAR-T cell therapy research 26
- Cancer Immunotherapy and Biomarkers 16
- Immunology top 1%
- Immunotherapy and Immune Responses 31
- Immune Cell Function and Interaction 13
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 14
- Viral Infectious Diseases and Gene Expression in Insects 11
- Biotechnology top 2%
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- James M. WilsonYiping YangMelinda VanRoeyKrishna J. FisherRolf MüllerThomas C. HardingNarendra ChirmuleHildegund C.J. Ertl
- Cited by
- GeneticsOncologyImmunology
- Journals
- Cancer Research (10 papers)Cancer Immunology Immunotherapy (6 papers)Human Gene Therapy (4 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Karin Jooss
72 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 2.5k
- Oncology 2.4k
- Immunology 1.7k
- Molecular Biology 3.2k
- Biotechnology 259
Countries citing papers authored by Karin Jooss
This map shows the geographic impact of Karin Jooss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Jooss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Jooss more than expected).
Fields of papers citing papers by Karin Jooss
This network shows the impact of papers produced by Karin Jooss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Jooss. The network helps show where Karin Jooss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karin Jooss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 33 | |
| 5 | 2022 | 31 | |
| 6 | 2013 | 21 | |
| 7 | 2013 | 63 | |
| 8 | 2009 | 153 | |
| 9 | 2008 | 47 | |
| 10 | 2008 | 15 | |
| 11 | 2007 | 83 | |
| 12 | Identification of antibody responses induced in patients with metastatic hormone-refractory prostate cancer (HRPC) treated with a GM-CSF-transduced allogeneic prostate cancer immunotherapy | 2007 | 1 |
| 13 | 2007 | 16 | |
| 14 | 2006 | 26 | |
| 15 | 2006 | 58 | |
| 16 | VEGFR-3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels | 2005 | 5 |
| 17 | 2003 | 71 | |
| 18 | 2003 | 25 | |
| 19 | 2003 | 224 | |
| 20 | 1998 | 107 |
About Karin Jooss
Karin Jooss is a scholar working on Immunology, Oncology and Genetics, having authored 74 papers that have together received 5.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), Virus-based gene therapy research (26 papers), CAR-T cell therapy research (26 papers), Cancer Immunotherapy and Biomarkers (16 papers), RNA Interference and Gene Delivery (14 papers), Immune Cell Function and Interaction (13 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Genetics (2.5k citations), Oncology (2.4k citations) and Immunology (1.7k citations). Karin Jooss has collaborated with scholars based in United States, Germany and France. Frequent co-authors include James M. Wilson, Yiping Yang, Melinda VanRoey, Krishna J. Fisher, Rolf Müller, Thomas C. Harding, Narendra Chirmule, Hildegund C.J. Ertl, Guang Huan Tu and Betty Li. Their work appears in journals such as Cancer Research, Cancer Immunology Immunotherapy, Human Gene Therapy, Clinical Cancer Research and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.